Stocktoria

FILANA THERAPEUTICS, INC. FLNA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2000-07-14

FILANA THERAPEUTICS, INC. statistics & valuation

Market cap$58.0M
P / B0.8×
Return on equity-122.3%
Return on capital-128%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2017201820192020202120222022202320242025
Operating margin (%)
2017201820192020202120222022202320242025
Return on equity (%)
-122.80% -33.40% -21.00% -6.90% -12.80% -33.50% -70.70% -16.70% -122.30% 2017201820192020202120222022202320242025
Shares outstanding
6.6M 17.2M 21.8M 35.2M 40.0M 40.1M 41.7M 42.2M 48.2M 48.3M 2017201820192020202120222022202320242025
Net debt ($)
2017201820192020202120222022202320242025
Share buybacks ($)
2017201820192020202120222022202320242025
Return on assets (%)
-110.00% -32.60% -19.70% -6.70% -12.10% -32.50% -64.10% -15.50% -76.90% 2017201820192020202120222022202320242025
Free cash flow margin (%)
2017201820192020202120222022202320242025
Debt / equity (×)
2017201820192020202120222022202320242025
EPS ($)
-$1.90 -$2.32 -$1.46 -$1.88 2017201820192020202120222022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2022FY2021FY2020FY2019FY2018FY2017
Return on assets-76.9%-15.5%-64.1%-32.5%—-12.1%-6.7%-19.7%-32.6%-110.0%
Return on equity-122.3%-16.7%-70.7%-33.5%—-12.8%-6.9%-21.0%-33.4%-122.8%
Current ratio2.2311.629.1329.9122.0619.5150.4016.8339.229.42

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.